Drug-induced hypohidrosis and anhidrosis: analysis of the WHO pharmacovigilance database 2000–2020
- 30 January 2022
- journal article
- letter
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 78 (5) , 887-889
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Pharmacovigilance – The next chapterTherapies, 2019
- Case–non-case studies: Principle, methods, bias and interpretationTherapies, 2019
- The French Levothyrox® crisis: We did the best we could but…Therapies, 2019
- Oxybutynin as an alternative treatment for hyperhidrosisAnais Brasileiros de Dermatologia, 2017
- Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic reviewJournal of the European Academy of Dermatology and Venereology, 2017
- Hypohidrosis induced by topiramate in an adult patientEpileptic Disorders, 2013
- Hypohidrosis and hyperthermia during topiramate treatment in childrenThe Turkish Journal of Pediatrics, 2012
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2011
- Drug-Induced Hyperhidrosis and HypohidrosisDrug Safety, 2008
- Nefopam AbuseAnnals of Pharmacotherapy, 2002